Stryker is a medical device company located in Michigan, United States, which is part of the Healthcare sector, and is traded under the ticker SYK on the NYSE exchange.
Stryker stock last closed at $353.22, up 1.19% from the previous day, and has increased 35.87% in one year. It has overperformed other stocks in the Medical Devices industry by 0.46 percentage points. Stryker stock is currently +41.3% from its 52-week low of $249.98, and -1.17% from its 52-week high of $357.40.
As of Mar 1, 2024, there are 380.26M SYK shares outstanding. The market value of SYK is $134.32B. In the past 24 hours, 1.31M SYK shares were traded.
You need an online brokerage account in order to access the NYSE market and buy SYK stock.
Based on our experience, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro now.Open eToro Account
Now that you've picked your brokerage, the next step is to fill out some personal info so you are able to buy SYK stock today.
Now that you have finished signing up on one of the best stock trading apps, you need to deposit funds:
Check out the walkthrough below if you need help transferring funds into your new brokerage account.
Once you have chosen the best place to buy Stryker stock, it's important to evaluate their stock prior to buying, so you can comprehend the risk as well as the opportunity.
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on SYK's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SYK's true value.
Using relative valuations ratios:
You can do additional valuation analysis on SYK's stock here.
Out of 9 sell side analysts who track SYK, the consensus analyst rating on Stryker is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Larry Biegelsen, a top 13% analyst from Wells Fargo maintains SYK with a strong buy rating and raises their SYK price target from $336.00 to $364.00, on Jan 31, 2024.
Wells Fargo's Larry Biegelsen raised their price target on Stryker (NYSE: SYK) by 8.3% from $336 to $364 on 2024/01/31. The analyst maintained their Strong Buy rating on the stock.
Biegelsen's update followed an assessment of Stryker's 2024/01/30-dated Q4 and FY 2023 earnings report and participation in the earnings call.
Management guided 7.5% to 9% organic sales growth and an $11.70 to $12 EPS for 2024, while Q4 sales and EPS easily surpassed expectations, the analyst told investors.
However, the midpoint of management's EPS guidance is well above consensus," Biegelsen noted.
For Q4 2023:
For FY 2023:
For FY 2024, management guided:
Chairman & CEO Kevin Lobo commented: "We drove excellent organic sales growth of over 11% in both Q4 and FY 2023, and delivered strong adjusted earnings.
"It was exciting to surpass $20B in sales as we continue to drive high growth.”
Drew Ranieri, a bottom 11% analyst from Morgan Stanley maintains SYK with a hold rating and raises their SYK price target from $300.00 to $320.00, on Dec 4, 2023.
Danielle Antalffy, a bottom 3% analyst from UBS maintains SYK with a hold rating and raises their SYK price target from $289.00 to $297.00, on Nov 9, 2023.
Travis Steed, a top 28% analyst from Bank of America upgrades SYK to a strong buy rating and announces their SYK price target of $315.00, on Sep 5, 2023.
You can dig deeper into what analysts are forecasting on the Stryker stock forecast page.
Last year, SYK earnings were $3.17B. During the past 5 year, SYK's earnings have gone up by -2.57% per year. This was slower than the Medical Devices industry average of 9.22%.
Last year, SYK revenue was $20.50B. In the past five year, SYK's revenue has increased by 8.55% per year. This was slower than the Medical Devices industry average of 12.74%.
Find out more about SYK's earnings and revenue performance here.
In the last year, insiders at SYK have sold more shares than they have bought.
Glenn S. Boehnlein, VP Chief Financial Officer of SYK, was the latest SYK insider to sell. They sold $3,290,956.80 worth of SYK shares on Feb 9, 2024.
Research more about who owns SYK shares here.
Stryker pays a dividend of 0.86%, compared to the Medical Devices industry's average dividend yield of 1.46%. If you owned $1,000 worth of SYK stock, you would have been paid $8.63 last year.
Stryker dividend payments have consistently grown over the past decade and have remained stable.
Dig into more info about Stryker dividend yield and history here.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two main options:
Press the Open button and your broker will place your order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Now that you own some SYK stock, you'll want to keep up with your new stock purchase.
Put SYK on a watchlist to track your SYK stock.
To summarize, here are the 6 steps to buy Stryker stock:
If you require a place to buy stocks, eToro is our recommended option.Get Started with eToro Today
If you want to keep track of your investment in Stryker, click the button below.
How much does it cost to buy one Stryker share?
Is now a good time to buy Stryker stock?
What is the best way to buy Stryker stock?